Login

Brian Cox, SurgePays CEO, discusses current $SURG fundamentals and more in this interview.|Kevin Brian Cox. Chairman/CEO, SurgePays Inc ; 00:10:00

Share On Facebook Share On Twitter

Kevin Brian Cox. Chairman/CEO, SurgePays Inc ;

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
"Brinova: Transforming Communities with Affordable Housing in Southern Sweden"|CEO,Brinova Fastigheter AB (publ)
00:10:00
Orvana's assets consist of the producing El Valle and Carlés gold-copper-silver mines in northern Spain and the Don Mario gold-silver property in Bolivia| Juan Gavidia, President and CEO of Orvana Minerals Corp
00:10:00
Fastly CEO Todd Nightingale delivers closing remarks at Altitude 2022, sharing comments on the company's performance and future outlook.
00:10:00
White Gold: Modern Exploration in Yukon's New Gold Rush
00:10:00
Transforming Investment Strategies: Resiliency, Higher Rates, and Private Alternatives | David Hunt, CEO , PGIM.
00:10:00
AI-Powered Mineral Exploration: Sensa's Revolutionary Approach
00:10:00
René Lacerte on Building Bill.com: Origins, Hiring Executives, Partnerships, and Company Culture | René Lacerte - CEO of BILL
00:10:00
Stanbic IBTC's Commitment to Succession Planning and Sustainable Growth | Dr. Demola Sogunle, CEO , Stanbic IBTC Holdings PLC.
00:10:00
Allegion's Transformational Path: Stories of Aaron and Heather | John H. Stone - CEO of Allegion
00:10:00
Pacifino Gold's Dugbe Project Update: Advancing Towards Production in Liberia
00:10:00
Glenn August on Credit Markets: Navigating Pandemic Recovery and Finding Value |Glenn August , CEO, Oak Hill Advisors.
00:10:00
"Robert F. Wallace on Managing Stanford's $35 Billion Investment Portfolio | Investment Conference 2024"

© 2017 - Neuhu+